BOXABL Inc. (NASDAQ: BXBL) is a technology company focused on transforming residential construction through a factory-built, modular housing system designed for scale. By shifting homebuilding from traditional on-site processes to controlled manufacturing environments, the company aims to introduce a more standardized, efficient and repeatable approach to housing production. Its model integrates design, engineering and manufacturing into a unified system intended to improve speed, cost predictability and overall accessibility.

The company's approach is rooted in addressing persistent structural challenges across the housing market, including affordability constraints, regulatory complexity and declining construction productivity. BOXABL's platform is designed to streamline the building process by reducing reliance on fragmented workflows and enabling consistent output through automation and standardized components. This system-level strategy is intended to support a wide range of housing applications while improving efficiency across the value chain.

View Full Profile and Other Resources

D-Wave Quantum Inc. (NASDAQ: QBTS) is a leader in quantum computing systems, software and services focused on delivering value to our customers via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow. Founded in 1999, D-Wave is the world's first commercial supplier of quantum computing solutions.

D-Wave is a pioneer in quantum computing, with a history of delivering the world's first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service), Ocean™ (full suite of open-source programming tools) and Quantum QuickStart™ (quantum programming training).

View Full Profile and Other Resources

Forward Industries Inc. (NASDAQ: FWDI) is building and managing a large-scale Solana (SOL) treasury, backed by some of the most influential investors in the digital asset space. The company's strategy centers on long-term shareholder value through active participation in the Solana ecosystem, which it views as uniquely positioned to underpin future global capital markets due to its high throughput, deep economic activity, and growing developer adoption.

Through this shift, Forward Industries aims to create value by accumulating SOL and strategically deploying assets through on-chain opportunities including staking, lending, and participation in decentralized finance (DeFi). Forward also became the first U.S.-listed company to bring its common stock onto the Solana blockchain, reinforcing its focus on digital-native capital markets.

View Full Profile and Other Resources

Greenland Energy Company (NASDAQ: GLND) is an exploration-focused oil and gas company targeting development in Greenland's Jameson Land Basin, a large and historically underexplored hydrocarbon region in the Arctic. The company was formed through the completed business combination of Pelican Acquisition Corporation, Greenland Exploration Limited, and March GL Company, creating a publicly traded platform designed to pursue large-scale resource opportunities.

The company's vision is to responsibly unlock Greenland's energy potential, supporting both local development and global energy security through science-driven exploration and innovation.

View Full Profile and Other Resources

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is a biotechnology company developing and commercializing artificial intelligence-powered health prediction technologies that use the human voice as a diagnostic input. The company's platform is centered on acoustic biomarker analysis, transforming speech into measurable physiological insights that can be used to detect drug and alcohol intoxication and support broader health monitoring applications. By leveraging voice as a non-invasive data source, MindBio is advancing a scalable approach to real-time diagnostics.

The company's technology is built on clinical trials and large-scale data analysis, with predictive models trained on more than 50 million data points and supported by multiple studies demonstrating high levels of accuracy in intoxication detection. This foundation enables both consumer-facing and enterprise-grade applications, positioning MindBio to address use cases ranging from personal awareness tools to workforce safety and regulatory compliance in high-risk industries.

View Full Profile and Other Resources

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company's AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.

View Full Profile and Other Resources

Perpetuals.com Ltd. (NASDAQ: PDC) is a publicly traded digital market infrastructure company enabling derivatives trading through a compliant, API-driven platform. Built as infrastructure rather than a balance-sheet exchange, the company provides brokers, institutions, and trading venues with access to crypto and tokenized derivatives while avoiding custody, credit, and counterparty exposure by design.

The platform addresses a structural gap created as demand for leveraged digital asset exposure has outpaced the availability of compliant market infrastructure, particularly in Europe. Regulatory constraints limit how traditional brokers can legally offer crypto leverage, while many existing trading venues operate outside regulated frameworks. Perpetuals is designed to function within these constraints by combining institutional-grade execution, real-time settlement, and structured product capabilities through infrastructure intended for use by regulated market participants.

View Full Profile and Other Resources

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) is a biopharmaceutical company focused on developing therapies and biotech solutions targeting neurodegenerative, metabolic and alcohol misuse disorders. The company is advancing a diversified platform spanning clinical-stage therapeutics, consumer-focused wellness products and strategic investments designed to address areas of significant unmet need.

The company's strategy combines pharmaceutical research and development with commercialization partnerships and licensing structures intended to support multiple potential revenue streams and long-term growth initiatives. Quantum BioPharma is advancing programs across multiple stages of development while leveraging scientific research, intellectual property and commercial relationships as part of its broader business strategy.

View Full Profile and Other Resources

Regentis Biomaterials Ltd. (NYSE American: RGNT) is taking aim at a $3 billion U.S. market with what could be the first true off-the-shelf solution for knee cartilage repair—no cells, no delays, no complexity. Its GelrinC® platform delivers faster recovery, stronger outcomes, and lower costs vs. outdated procedures, with clinical data showing ~100% greater pain improvement vs. microfracture. Already CE Mark approved in Europe and advancing through a pivotal U.S. Phase III trial, Regentis is stacked with near-term catalysts that could redefine orthopedic care—and unlock massive upside.

Regentis is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore health and enhance quality of life. With an initial focus on knee injuries and other orthopedic treatments, Regentis' Gelrin™ platform technology, based on synchronized, degradable hydrogel implants, regenerates damaged or diseased tissue including inflamed cartilage and bone.

View Full Profile and Other Resources

Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro's mission is its patented artificial intelligence (AI), machine learning (ML), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (UXO), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company's vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

View Full Profile and Other Resources

SS Innovations International, Inc. (NASDAQ: SSII) develops differentiated surgical robotic technologies, highlighted by its advanced, cost-efficient SSi Mantra surgical robotic system. Spearheaded by a team of visionary engineers and Dr. Sudhir Srivastava, an acclaimed robotic cardiac surgeon and the company's founder, Chairman and Chief Executive Officer, the SSi Mantra features differentiated capabilities in areas such as telesurgery, cardiac surgery and pediatric procedures. The SSi Mantra's broad-based surgical robotic applications, modularity, user friendliness, training capabilities, clinical track record and relative cost advantages have contributed to its early commercial success.

SS Innovations is a rapidly growing American company headquartered in India and expanding globally with an eye on democratizing access to cutting-edge surgical robotic technologies. After commencing commercial operations in late 2022, the company's annual revenue has grown from approximately $5.9 million in 2023 to $42.5 million in 2025, corresponding to a compounded annual growth rate of 169%. Nearly 500 employees and more than 90,000 square feet of world-class R&D and manufacturing facilities support the company's growth.

View Full Profile and Other Resources

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) is a North American mineral exploration and development company focused on advancing high-grade copper and critical mineral assets in Alaska. The company operates through Ambler Metals LLC, a 50/50 joint venture with South32 Ltd., and is progressing one of the world's most prospective undeveloped polymetallic districts.

Trilogy is uniquely positioned with exposure to copper, zinc, lead, cobalt, silver, and gold—commodities vital to global electrification and energy transition. Its vision is to responsibly develop the Ambler Mining District into a premier domestic source of critical minerals while delivering long-term value to shareholders and local communities.

View Full Profile and Other Resources

VERAXA Biotech AG (NASDAQ: VRXA) is a biotechnology company focused on the discovery and development of a new generation of antibody-based therapeutics for the treatment of solid tumors. VERAXA's vision is to deliver the next wave of smart cancer therapies with curative potential and improved safety profiles.

The company is building a pipeline that includes dual-targeting antibody-drug conjugates ("ADCs") and T-cell engagers ("TCEs") predominantly based on its patented BiTAC concept. This concept is designed to improve the precision, safety, and effectiveness of cancer treatments. Through its focus on potentially first-in-class conditionally active ADC and TCE platforms, VERAXA is positioned within two rapidly growing segments of the global oncology therapeutics market.

View Full Profile and Other Resources

Versus Systems Inc. (NASDAQ: VS) is a technology company focused on enhancing how audiences interact with content across digital and live environments. The company's platform enables brands, teams, and content creators to integrate interactive elements directly into their experiences, allowing users to participate in games and earn real-world rewards while engaging with media.

By combining gameplay mechanics with promotional functionality, Versus provides a framework for turning passive audiences into active participants. Its patented earned-rewards system is designed to operate across mobile, web, broadcast, and in-venue formats, supporting both audience participation and measurable brand interaction without requiring significant development resources.

View Full Profile and Other Resources

Wrap Technologies, Inc. (NASDAQ: WRAP) is a public safety technology company built around its Non-Lethal Response™ ("NLR") platform. Rather than positioning itself as a single-product device maker, the company describes its 2025—2026 transformation as building an integrated system of tools, training, and policy support — now extending toward a platform that connects advanced sensing, artificial intelligence, command-and-control, and measured response — designed to help law enforcement, corrections, defense, border security, campus safety, and healthcare security personnel manage encounters more safely and reduce reliance on higher levels of force.

WRAP's flagship product is the BolaWrap® 150, a patented, remote restraint device that deploys a Kevlar tether to help officers gain control of non-compliant individuals from a distance without pain compliance. WRAP describes it as the only remote response-to-resistance tool designed to maintain a safe distance between subject and officer, deployed early in the pre-escalation phase of the force continuum. The company cites adoption by more than 1,000 agencies across the U.S. and in 50+ countries and zero reported fatalities associated with the device. In July 2026, the U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) ruled that the BolaWrap® 150 is an instrument of restraint rather than a firearm or "any other weapon" under federal law.

View Full Profile and Other Resources